Todd Asset Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-916,390
Closed -$8.48M 225
2015
Q4
$8.48M Sell
916,390
-409,255
-31% -$4.48M 0.26% 134
2015
Q3
$16.9M Sell
1,325,645
-267,525
-17% -$3.32M 0.53% 60
2015
Q2
$17.6M Sell
1,593,170
-134,705
-8% -$1.49M 0.48% 64
2015
Q1
$19.7M Buy
1,727,875
+6,205
+0.4% +$65.8K 0.55% 54
2014
Q4
$17.4M Sell
1,721,670
-89,445
-5% -$942K 0.48% 64
2014
Q3
$19M Buy
1,811,115
+17,760
+1% +$167K 0.55% 59
2014
Q2
$15.5M Buy
1,793,355
+243,540
+16% +$2.05M 0.44% 74
2014
Q1
$13.6M Buy
+1,549,815
New +$13.5M 0.39% 85

Other funds holding RDY

Todd Asset Management's RDY Position: Q1 2016 in Review

Todd Asset Management sold out of Dr. Reddy's Laboratories (RDY) in Q1 2016, closing a stake of 916,390 shares — an estimated $8.48M sold.

Todd Asset Management first reported a position in RDY in Q1 2014 and held it in 8 quarters. The position peaked at $19.7M in Q1 2015. 160 funds tracked by Wall St. Rank hold RDY as of Q1 2016.

  • Todd Asset Management reported no remaining Dr. Reddy's Laboratories position as of Q1 2016 after selling out during the quarter.
  • Todd Asset Management sold 916,390 Dr. Reddy's Laboratories shares in Q1 2016, an estimated $8.48M.
  • Todd Asset Management first reported a position in Dr. Reddy's Laboratories in Q1 2014 and held it in 8 quarters.
  • Todd Asset Management's Dr. Reddy's Laboratories position peaked at $19.7M in Q1 2015.
  • 160 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2016.

Based on Todd Asset Management's 13F filing for Q1 2016, filed 9 May 2016.